KLARSEN |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.825 EUR | +0.18% |
|
-2.59% | +3.86% |
| 15/03 | Acticor Biotech Raises EUR8 Million to Fund Emergency Stroke Treatment Development | MT |
| 2023 | Acticor Biotech’s Phase 2/3 Trial for Stroke Drug Combo on Track for 2024 Results | MT |
- Stock Market
- Equities
- ALKLA Stock
- News Klarsen
- Analyst Reco.
